Overview
Epileptic encephalopathy with global cerebral demyelination is an extremely rare and severe neurological condition that affects the brain in two major ways. First, it causes epileptic encephalopathy, which means the brain experiences frequent and difficult-to-control seizures that interfere with normal brain development and function. Second, it involves global cerebral demyelination, meaning the protective covering (called myelin) around nerve fibers throughout the brain breaks down or fails to form properly. Myelin acts like insulation on electrical wires, helping brain signals travel quickly and efficiently. When myelin is damaged, the brain cannot communicate properly, leading to serious problems with movement, thinking, and development. Children with this condition typically present very early in life with seizures that are resistant to standard anti-seizure medications. They also show significant developmental delays or regression, meaning they may lose skills they had previously gained. Brain MRI scans reveal widespread loss of the white matter (myelin) in the brain. The condition is classified under metabolic disorders (ICD-10 code E88.8), suggesting an underlying metabolic or biochemical cause that disrupts both brain electrical activity and myelin maintenance. The treatment landscape for this condition is currently very limited. Management focuses primarily on controlling seizures as much as possible with anti-epileptic medications and providing supportive care including physical therapy, nutritional support, and management of complications. There is no cure or disease-modifying treatment available at this time, and the prognosis is generally poor.
Key symptoms:
Severe seizures that are hard to control with medicationDevelopmental delay or loss of previously learned skillsMuscle stiffness or spasticityWeak muscle tone (floppiness) in early infancyDifficulty feeding or swallowingPoor head controlVision problems or lack of visual trackingIntellectual disabilityFailure to reach developmental milestones like sitting or walkingAbnormal movements or posturingIrritability or excessive cryingBreathing difficultiesReduced responsiveness or alertness
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Neonatal
Begins at or shortly after birth (first 4 weeks)
FDA & Trial Timeline
1 eventAndrew Dauber — PHASE2
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Epileptic encephalopathy with global cerebral demyelination.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Epileptic encephalopathy with global cerebral demyelination at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Epileptic encephalopathy with global cerebral demyelination.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Epileptic encephalopathy with global cerebral demyelination.
Community
No community posts yet. Be the first to share your experience with Epileptic encephalopathy with global cerebral demyelination.
Start the conversation →Latest news about Epileptic encephalopathy with global cerebral demyelination
No recent news articles for Epileptic encephalopathy with global cerebral demyelination.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What is the specific genetic cause of my child's condition, and has genetic testing been completed?,What seizure medications are we going to try, and what are the possible side effects?,Should we consider a ketogenic diet for seizure control?,What therapies (physical, occupational, speech) should my child be receiving, and how often?,What is the expected course of this condition, and how should we plan for the future?,Are there any clinical trials or research studies that my child might be eligible for?,Should we involve a palliative care team, and what support services are available for our family?
Common questions about Epileptic encephalopathy with global cerebral demyelination
What is Epileptic encephalopathy with global cerebral demyelination?
Epileptic encephalopathy with global cerebral demyelination is an extremely rare and severe neurological condition that affects the brain in two major ways. First, it causes epileptic encephalopathy, which means the brain experiences frequent and difficult-to-control seizures that interfere with normal brain development and function. Second, it involves global cerebral demyelination, meaning the protective covering (called myelin) around nerve fibers throughout the brain breaks down or fails to form properly. Myelin acts like insulation on electrical wires, helping brain signals travel quickly
How is Epileptic encephalopathy with global cerebral demyelination inherited?
Epileptic encephalopathy with global cerebral demyelination follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Epileptic encephalopathy with global cerebral demyelination typically begin?
Typical onset of Epileptic encephalopathy with global cerebral demyelination is neonatal. Age of onset can vary across affected individuals.